Matrixmetalloproteinase-9 Genetic Variation with Cataract, Glaucoma and Retinoblastoma in a Senegalese Population
International Journal of Healthcare and Medical Sciences · 2019
DOI: 10.32861/ijhms.510.52.58 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Healthcare and Medical Sciences, 2019. Verfasst von Matar Ciss und 6 weiteren Autor:innen.
Abstract (Originalsprache)
The Matrix metalloproteinase-9 is involved in several pathologies. Its strong presence in ocular pathologies explains our interest for its genetic variation in cataract, glaucoma and retinoblastoma in Senegal. MMP9 is highly polymorphic with cataract and glaucoma. 77 mutations were noted with 21 haplotypes for the entire population. The haplotype diversity Hd is 0.831 and the nucleotide diversity Pi is 0.016; k = 17.395. The polymorphism of the Matrix metalloproteinase-9 gene is associated with all three diseases and SNP 3918249 is found in both cataract and glaucoma.
Zitieren
APA
Ciss, M., Guéye, N. N., Mbaye, F., Ndoye, P. A., Dial, C., Ndiaye, J., & Sembéne, M. (2019). Matrixmetalloproteinase-9 Genetic Variation with Cataract, Glaucoma and Retinoblastoma in a Senegalese Population. International Journal of Healthcare and Medical Sciences. https://doi.org/10.32861/ijhms.510.52.58
Vancouver
Ciss M, Guéye NN, Mbaye F, Ndoye PA, Dial C, Ndiaye J, et al. Matrixmetalloproteinase-9 Genetic Variation with Cataract, Glaucoma and Retinoblastoma in a Senegalese Population. International Journal of Healthcare and Medical Sciences. 2019. doi:10.32861/ijhms.510.52.58
BibTeX
@article{Ciss2019,
author = {Ciss, Matar and Guéye, Ndéye Ndoumbé and Mbaye, Fatimata and Ndoye, Paul Aїda and Dial, Chérif and Ndiaye, Joseph and Sembéne, Mbacké},
title = {Matrixmetalloproteinase-9 Genetic Variation with Cataract, Glaucoma and Retinoblastoma in a Senegalese Population},
journal = {International Journal of Healthcare and Medical Sciences},
year = {2019},
doi = {10.32861/ijhms.510.52.58}
}
EUVIMED